Method for treating infection by hepatitis C virus (HCV) admninistrar comprising an inhibitor of HCV NS3 serine protease.An inhibitor of RNA dependent rna polymerase of HCV NS5b and optionally Pharmaceutical composition； Ribavirin； Case； and its use for the treatment of hcv infection.

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

发明人:

BOECHER, WULF,HAEFNER, CARLA,KUKOLJ, GEORGE

申请号：

CL2013000670

公开号：

CL2013000670A1

申请日:

2013.03.11

申请国别(地区):

CL

年份:

2013

代理人:

摘要：

The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) Compound (2), or a pharmaceutically acceptable salt thereof, as herein described, and optionally (c) ribavirin, and methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.USO DE UN COMPUESTO INHIBIDOR DE LA SERINA PROTEASA NS3 DEL HVC, JUNTO CON UN COMPUESTO INHIBIDOR DE LA ARN POLIMERASA DEPENDIENTE DE ARN NS5B DE HCV Y OPCIONALMENTE RIBAVIRINA, PARA TRATAR UNA INFECCIÓN POR VIRUS DE LA HEPATITIS C (HCV).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/